Johnson & Johnson to Participate in the Virtual Wells Fargo Healthcare Conference Johnson & Johnson (NYSE: JNJ) will participate in the Virtual Wells Fargo Healthcare Conference on Friday, September 10th. Joaquin Duato, Vice...
Tuesday, July 27, 2021 BiopharmaWatch Research 1 min read
Key Takeaway: NEW BRUNSWICK, N.J. , July 27, 2021 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ ) will participate in the Virtual Wells Fargo Healthcare Conference on Friday, September 10 th . Joaquin Duato, Vice Chairman of the Executive Committee will represent the Company in a session schedu
Price reaction · baseline $171.87 (2021-07-26 close) · hit after-hours · clean, no other JNJ news in the window
day 0 close · peak
+0.5%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+34%
120-day peak, hindsight
Typical move
1.6%
average across 15 past catalysts
Lead asset
Canagliflozin
Phase 3 · Diabetes Mellitus, Type 2
Full Press Release Details
NEW BRUNSWICK, N.J. , July 27, 2021 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ ) will participate in the Virtual Wells Fargo Healthcare Conference on Friday, September 10 th . Joaquin Duato, Vice Chairman of the Executive Committee will represent the Company in a session scheduled at 10:00 a.m. (Eastern Time) .
This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com .
A webcast replay will be available approximately 48-hours after the live webcast.